Synthetic data boosts readmission prediction
Objective:
To evaluate the effectiveness of synthetic data in predicting 30-day hospital readmissions for patients with type 2 diabetes, COPD, and heart failure.
Key Findings:
- Models using synthetic data outperformed those using original data alone, with AUROC values ranging from 0.91 to 0.95.
- Gradient boosting achieved the highest performance in COPD and type 2 diabetes, while extreme gradient boosting excelled in heart failure.
- Higher illness severity scores and greater comorbidity burden were key predictors of readmission.
- Medication nonadherence significantly increased the odds of readmission across all conditions.
Interpretation:
Incorporating synthetic data and social/behavioral risk factors enhances predictive accuracy, supporting multidimensional risk prediction frameworks.
Limitations:
- Single-center dataset without external validation may limit generalizability.
- Potential underdocumentation of social determinants of health could affect findings.
- Lack of evaluation of real-world implementation or cost-effectiveness limits practical application.
Conclusion:
The study highlights the potential of synthetic data in improving readmission prediction models, emphasizing the integration of social and behavioral factors.
AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.